Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
December 8, 2009
Patent Application Number
12021530
Date Filed
January 29, 2008
Patent Primary Examiner
Patent abstract
The invention refers to the use of specific cyclolignans, wherein the carbon atoms in positions 9 and 9′ have cis configuration, for inhibition of the insulin-like growth factor-1 receptor. Said compounds can be used for treatment of IGF-1R dependent diseases, such as cancer, psoriasis, artherosclerosis and acromegaly. A preferred compound is picropodophyllin.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
